Laetitia Marzi Selected Research

LMP517

1/2020

The Indenoisoquinoline LMP517: A Novel Antitumor Agent Targeting both TOP1 and TOP2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laetitia Marzi Research Topics

Disease

5	Neoplasms (Cancer) 01/2020 - 02/2011
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020 - 01/2018
2	Colonic Neoplasms (Colon Cancer) 07/2012 - 02/2011
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2020
1	Diarrhea 01/2020
1	Carcinoma (Carcinomatosis) 01/2018
1	Leukemia 01/2018
1	Adenocarcinoma 07/2012
1	Colorectal Neoplasms (Colorectal Cancer) 02/2011

Drug/Important Bio-Agent (IBA)

4	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 02/2011
3	Topotecan (Hycamtin)FDA LinkGeneric 01/2020 - 01/2018
2	indimitecanIBA 01/2020 - 01/2018
2	CamptothecinIBA 01/2020 - 07/2012
1	NSC 724998IBA 01/2020
1	tyrosyl-DNA phosphodiesteraseIBA 01/2020
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2020
1	LMP517IBA 01/2020
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2020
1	olaparibIBA 10/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2019
1	Histones (Histone)IBA 01/2018
1	Mitogen-Activated Protein KinasesIBA 07/2012
1	Mitogen-Activated Protein Kinase 14IBA 07/2012
1	p38 Mitogen-Activated Protein KinasesIBA 02/2011

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 07/2012 - 02/2011
1	Radiotherapy 07/2012